Related Experiment Video
Updated: Apr 23, 2026

03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
2.3K
Optimal follow-up duration for nonspecific pleuritis: how long is long enough?
Semanur Ozyavuz1, Guntulu Ak1,2, Selma Metintas2,3
1Eskisehir Osmangazi University, Medical Faculty, Department of Chest Disease, Eskisehir, Turkey.
ERJ Open Research
|April 22, 2026
Summary
Nontuberculous mycobacterial pulmonary infections (NSP) are usually benign. However, some NSP cases may develop into malignancy, particularly mesothelioma, necessitating structured follow-up for high-risk patients.
Area of Science:
- Pulmonology
- Oncology
- Infectious Diseases
Background:
- Nontuberculous mycobacterial pulmonary infections (NSP) are generally considered benign conditions.
- However, a subset of NSP cases has been associated with the later development of malignancy, notably mesothelioma.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
1.3K
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.3K
Pneumothorax-II
1.6K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.6K
Endocarditis III: Medical Management
356
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
356
Acute Pyelonephritis II: Diagnostic Studies and Management
808
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
808
Pneumonia III: Complications and Assessment
1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K